PPH Legal Blog

Over a dozen new Avandia lawsuits were filed in late August, after many more people have suffered the dangerous effects of Avandia, a drug meant to treat diabetes. The new lawsuits have one common claim - patients were never warned about the dangerous effects of the drug.

Many people have developed a heart condition known as primary pulmonary hypertension (PPH) as a result of using GlaxoSmithKline’s Avandia. The Food and Drug Administration has been investigating the drug and has concluded that diabetics taking Avandia have a much higher risk of suffering a heart attack.

According to one of the new lawsuits, the warnings on the drug were “vague, incomplete, or otherwise inadequate.” GlaxoSmithKline also states that Avandia has the ability to reduce cardiovascular risk, which the FDA has never concluded about any oral diabetic medication.

Those suffering from the dangerous health effects of Avandia should speak with a PPH lawyer right away. Contact the PPH lawyers of Williams Kherkher today by calling 866-950-9000.

Lany Standford, a type 2 diabetic, died after suffering a heart attack in May, 2007. He had been prescribed Avandia to regulate his insulin levels; however, the drug turned out to be more dangerous than the condition it was meant to treat.

Stanford’s family has filed a wrongful death lawsuit against the manufacturer, GlaxoSmithKline. According to the GlaxoSmithKline website, Avandia was approved by the FDA, however the Stanfords believe that the manufacturing company falsely convinced the FDA that their drug was safe.

New reports help to reinforce this claim as it has been discovered that GlaxoSmithKline withheld some vital information from the FDA when the drug was initially approved.

For more information on Avandia or primary pulmonary hypertension, contact the PPH lawyers of Williams Kherkher.

The United States Food and Drug Administration has been investigating the drug Avandia for some time now. In early 2008, the FDA issued a warning letter to the drug’s manufacturer, GlaxoSmithKline, for postmarketing safety reporting failures.

The large manufacturer claims that any information that was withheld was done so by mistake. GlaxoSmithKline states that the missing information was “inadvertent and not intentional.”  The manufacturer informed the FDA that it would work to ensure that the mistake would never happen again by providing their employees with additional training on reporting requirements.

Although the FDA is working to keep the public informed and safe from dangerous drugs, their attempts may be too late for some who have suffered the dangerous effects associated with Avandia. Back in November 2007, the FDA issued the requirement that a black box warning be placed on the medicine’s packaging, stating that the drug could increase the risk of a heart attack.

If you or a loved one has been injured due to the use of Avandia, contact the PPH lawyers of Williams Kherkher today by calling 866-950-9000.

Recent studies have shown that the drug known as Viagra has been successful in the treatment of primary pulmonary hypertension (PPH) in infants. Viagra, best known to treat erectile dysfunction in adult males, has proven to be effective as a pulmonary dilator.

According to doctors, Viagra works to loosen and relax the constricted arteries of a baby suffering from PPH. The Viagra therapy allows the blood to flow more naturally through the lung arteries as it loosens the vessels.

Infants are given the drug in liquid form, making it easier for them to swallow. While Viagra treatments can carry some risks for infants, the overall benefits of the drug have already saved many lives.

If you are suffering from PPH caused by the use of unsafe diet pills, contact an attorney for information on your legal rights. The PPH lawyers of Williams Kherkher have extensive experience handling these types of cases. Call 866-950-9000 to speak with an experienced lawyer today.

In early July, GeneraMedix was approved by the FDA for its Epoprostenol for injection 1.5mg drug. GeneraMedix’s Epoprostenol for injection 1.5mg is meant to be a long-term intravenous treatment for primary pulmonary hypertension (PPH).

PHH is caused by the thinning or narrowing of the blood vessels that supply the lungs. If left untreated, an individual’s blood pressure can rise to unhealthy levels, causing heart damage and even death.

The onset of PPH has been linked to the use of unsafe diet pills. If you or a loved one have taken diet pills and now suffer from PPH, it is in your best interest to contact an attorney immediately. The PPH lawyers of Williams Kherkher have been defending the rights of diet pill victims for many years and have the experience to help you through ths difficult time.

Contact the PPH lawyers of Williams Kherkher by calling 866-950-9000 today.